DK3843702T3 - Fastdosiskombination af memantin og donepezil til øjeblikkelig frigivelse - Google Patents
Fastdosiskombination af memantin og donepezil til øjeblikkelig frigivelse Download PDFInfo
- Publication number
- DK3843702T3 DK3843702T3 DK20732664.6T DK20732664T DK3843702T3 DK 3843702 T3 DK3843702 T3 DK 3843702T3 DK 20732664 T DK20732664 T DK 20732664T DK 3843702 T3 DK3843702 T3 DK 3843702T3
- Authority
- DK
- Denmark
- Prior art keywords
- memantin
- donepezil
- immediate
- dose combination
- release fixed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT11555719 | 2019-05-31 | ||
| PCT/IB2020/055137 WO2020240505A1 (en) | 2019-05-31 | 2020-05-29 | Immediate release fixed-dose combination of memantine and donepezil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3843702T3 true DK3843702T3 (da) | 2023-10-09 |
Family
ID=71092565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20732664.6T DK3843702T3 (da) | 2019-05-31 | 2020-05-29 | Fastdosiskombination af memantin og donepezil til øjeblikkelig frigivelse |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP4238555A3 (da) |
| BR (1) | BR112021024054A2 (da) |
| CL (1) | CL2021002911A1 (da) |
| CO (1) | CO2021014967A2 (da) |
| DK (1) | DK3843702T3 (da) |
| FI (1) | FI3843702T3 (da) |
| HR (1) | HRP20231200T1 (da) |
| IL (1) | IL288505A (da) |
| MX (2) | MX2021014673A (da) |
| PE (1) | PE20220936A1 (da) |
| PT (1) | PT3843702T (da) |
| SA (1) | SA521430969B1 (da) |
| SI (1) | SI3843702T1 (da) |
| WO (1) | WO2020240505A1 (da) |
| ZA (2) | ZA202110478B (da) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| ES2059602T3 (es) | 1989-04-14 | 1994-11-16 | Merz & Co Gmbh & Co | Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral. |
| WO1997046526A1 (en) | 1996-06-07 | 1997-12-11 | Eisai Co., Ltd. | Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production |
| PT1509232E (pt) | 2002-05-31 | 2009-01-07 | Lundbeck & Co As H | Uma combinação de um antagonista de nmda e inibidores da acetilcolina esterase para o tratamento da doença de alzheimer |
| TW200418446A (en) | 2002-10-24 | 2004-10-01 | Merz Pharma Gmbh & Co Kgaa | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
| JP5025468B2 (ja) * | 2004-06-17 | 2012-09-12 | メルツ・ファルマ・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト・アウフ・アクティーン | メマンチン又はネラメキサンの直接圧縮によって製造された、飲用に適した即効型錠剤 |
| WO2006076562A1 (en) | 2005-01-11 | 2006-07-20 | Teva Pharmaceutical Fine Chemicals S.R.L. | Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride |
| ATE481096T1 (de) | 2005-04-06 | 2010-10-15 | Adamas Pharmaceuticals Inc | Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen |
| CN101166543B (zh) * | 2005-04-28 | 2014-07-16 | 卫材R&D管理有限公司 | 含抗痴呆药物的组合物 |
| DE102005060377A1 (de) * | 2005-12-16 | 2007-06-21 | Ratiopharm Gmbh | Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung |
| CN105816441A (zh) * | 2016-05-31 | 2016-08-03 | 北京康立生医药技术开发有限公司 | 盐酸美金刚多奈哌齐复方制剂 |
| KR101938872B1 (ko) * | 2016-09-30 | 2019-01-16 | 주식회사 바이오파마티스 | 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법 |
| WO2018062941A1 (ko) * | 2016-09-30 | 2018-04-05 | 주식회사 바이오파마티스 | 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법 |
-
2020
- 2020-05-29 BR BR112021024054A patent/BR112021024054A2/pt unknown
- 2020-05-29 PE PE2021001939A patent/PE20220936A1/es unknown
- 2020-05-29 WO PCT/IB2020/055137 patent/WO2020240505A1/en not_active Ceased
- 2020-05-29 PT PT207326646T patent/PT3843702T/pt unknown
- 2020-05-29 SI SI202030282T patent/SI3843702T1/sl unknown
- 2020-05-29 EP EP23177087.6A patent/EP4238555A3/en active Pending
- 2020-05-29 MX MX2021014673A patent/MX2021014673A/es unknown
- 2020-05-29 HR HRP20231200TT patent/HRP20231200T1/hr unknown
- 2020-05-29 FI FIEP20732664.6T patent/FI3843702T3/fi active
- 2020-05-29 DK DK20732664.6T patent/DK3843702T3/da active
- 2020-05-29 EP EP20732664.6A patent/EP3843702B1/en active Active
-
2021
- 2021-11-04 CL CL2021002911A patent/CL2021002911A1/es unknown
- 2021-11-05 CO CONC2021/0014967A patent/CO2021014967A2/es unknown
- 2021-11-29 SA SA521430969A patent/SA521430969B1/ar unknown
- 2021-11-29 IL IL288505A patent/IL288505A/en unknown
- 2021-11-29 MX MX2025002148A patent/MX2025002148A/es unknown
- 2021-12-15 ZA ZA2021/10478A patent/ZA202110478B/en unknown
-
2023
- 2023-12-18 ZA ZA2023/11560A patent/ZA202311560B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2025002148A (es) | 2025-04-02 |
| MX2021014673A (es) | 2022-01-11 |
| HRP20231200T1 (hr) | 2024-01-19 |
| BR112021024054A2 (pt) | 2022-01-11 |
| EP4238555A2 (en) | 2023-09-06 |
| IL288505A (en) | 2022-01-01 |
| CO2021014967A2 (es) | 2021-11-19 |
| CL2021002911A1 (es) | 2022-07-15 |
| PE20220936A1 (es) | 2022-05-31 |
| FI3843702T3 (fi) | 2023-10-09 |
| SA521430969B1 (ar) | 2023-12-05 |
| ZA202311560B (en) | 2024-07-31 |
| EP3843702A1 (en) | 2021-07-07 |
| EP4238555A3 (en) | 2023-09-20 |
| SI3843702T1 (sl) | 2023-12-29 |
| EP3843702B1 (en) | 2023-07-05 |
| ZA202110478B (en) | 2024-08-28 |
| WO2020240505A1 (en) | 2020-12-03 |
| PT3843702T (pt) | 2023-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3774789T3 (da) | BRM-målrettede forbindelser og tilhørende fremgangsmåder til anvendelse | |
| DK4480953T3 (da) | Tyk2-hæmmere og anvendelser deraf | |
| DK3966207T3 (da) | Phenylaminopyrimidinamid-autophagi-hæmmere og fremgangsmåder til anvendelse deraf | |
| DK3966206T3 (da) | Heteroarylaminopyrimidinamid-autophagihæmmere og fremgangsmåder til anvendelse deraf | |
| DK3947375T3 (da) | Imidazolonylquinolinforbindelser og terapeutiske anvendelser deraf | |
| DK3788044T3 (da) | RIP1-hæmmende forbindelser og fremgangsmåder til fremstilling og anvendelse heraf | |
| DK3858977T3 (da) | Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf | |
| DK3753937T3 (da) | Atr-hæmmer og anvendelse deraf | |
| DK3629838T3 (da) | Bærbar stol og fremgangsmåder til fremstilling af en bærbar stol | |
| DK4206216T3 (da) | Adeno-associerede virusvarianter og fremgangsmåder til brug deraf | |
| DK3445388T3 (da) | Materialer og fremgangsmåder til behandling af hæmoglobinopatier | |
| DK3506745T3 (da) | Insektfælde og fremgangsmåde | |
| DK3620174T3 (da) | Enhedsdosis af dengue-vaccine og indgivelse deraf | |
| DK3594199T3 (da) | Krystallinsk 2-flour-3-nitrotoluen og proces til forberedelse deraf | |
| DK3644999T3 (da) | Sammensætninger og fremgangsmåder til anvendelse af 2-(4-chlorphenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoracetamid | |
| DK3574135T3 (da) | Fremgangsmåde og formulering til fremstilling af ligninfibre | |
| DK3743088T3 (da) | IL-22 Fc-sammensætninger og fremgangsmåder til anvendelse | |
| DK3720875T3 (da) | Antimikrobielle peptider og fremgangsmåder til anvendelse deraf | |
| DK4034535T3 (da) | Aza-quinolinforbindelser og anvendelser deraf | |
| DK3981390T3 (da) | Farmaceutisk lacosamid-sammensætning og farmaceutisk præparat deraf | |
| DK3684344T3 (da) | Deferipron-tabletter med forsinket frigivelse og fremgangsmåder til anvendelse deraf | |
| DK3570739T3 (da) | Indretninger og fremgangsmåder til at bestemme hjertefunktionen hos en levende person | |
| DK3618772T3 (da) | Form og fremgangsmåde til fremstilling af en ortopædisk spacer af medicinsk cement | |
| DK3841066T3 (da) | Afsaltningssystem og fremgangsmåde | |
| DK3863759T3 (da) | Kavitationsreaktor og fremgangsmåde til fremstilling deraf |